Notably, although tumour‐bearing mice from CD74KO HCC cells achieved complete tumour regression after the combined treatment of anti‐PD1 antibody and LSD1 inhibitor, tumour recurrence occurred after discontinuation of the combined therapy. This evidence concerns the gene KDM1A and hepatocellular carcinoma.